deltatrials
Unknown PHASE4 NCT00108706

Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)

Sponsor: City Hospitals Sunderland NHS Foundation Trust

Conditions Acute Stroke Cerebrovascular Accident
Interventions Candesartan
Updated 5 times since 2017 Last updated: Sep 11, 2006 Started: Dec 31, 2004 Completion: Sep 30, 2007

A PHASE4 clinical study on Acute Stroke and Cerebrovascular Accident, this trial is ongoing. The trial is conducted by City Hospitals Sunderland NHS Foundation Trust and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    First recorded

Dec 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • City Hospitals Sunderland NHS Foundation Trust
  • Takeda
Data source: City Hospitals Sunderland NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Sunderland, United Kingdom